POSSIBLE ROLE OF CD22, CD79B AND CD20 EXPRESSION IN DISTINGUISHING SMALL LYMPHOCYTIC LYMPHOMA FROM CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Jovanovic, Danijela [1 ]
Djurdjevic, Predrag [1 ]
Andjelkovic, Nebojsa [1 ]
Zivic, Ljubica [1 ]
机构：
[1] Clin Ctr Kragujevac, Kragujevac, Serbia
来源：
CYTOMETRY PART B-CLINICAL CYTOMETRY | 2012年 / 82B卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：405 / 405
页数：1
相关论文
共 50 条
  • [21] CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection
    JA Garcia Vela
    I Delgado
    L Benito
    MC Monteserin
    L Garcia Alonso
    N Somolinos
    MA Andreu
    F Oña
    Leukemia, 1999, 13 : 1501 - 1505
  • [22] Abnormal levels of the α chain of the CD22 adhesion molecule may account for low CD22 surface expression in chronic lymphocytic leukemia
    B Payelle-Brogard
    G Dumas
    C Magnac
    A I Lalanne
    G Dighiero
    F Vuillier
    Leukemia, 2006, 20 : 877 - 878
  • [23] Immunophenotyping of chronic lymphocytic leukemia/small lymphocytic lymphoma for expression of CD27, IgD, IgM and CD38
    Li, Y
    Kussick, SJ
    Sabath, DE
    Wood, BL
    LABORATORY INVESTIGATION, 2002, 82 (01) : 250A - 251A
  • [24] High levels of CD20 expression predict good prognosis in chronic lymphocytic leukemia
    Fang, Cheng
    Zhuang, Yun
    Wang, Li
    Fan, Lei
    Wu, Yu-Jie
    Zhang, Run
    Zou, Zhi-Jian
    Zhang, Li-Na
    Yang, Shu
    Xu, Wei
    Li, Jian-Yong
    CANCER SCIENCE, 2013, 104 (08) : 996 - 1001
  • [25] DOWNREGULATION OF CD19, CD20 AND CD22 SURFACE EXPRESSION ON MANTLE CELL LYMPHOMA BY LENALIDOMIDE
    Eve, E.
    Richardson, J.
    Rule, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 608 - 609
  • [26] REDUCED EXPRESSION OF CD20 ANTIGEN AS A CHARACTERISTIC MARKER FOR CHRONIC LYMPHOCYTIC-LEUKEMIA
    ALMASRI, NM
    DUQUE, RE
    ITURRASPE, J
    EVERETT, E
    BRAYLAN, RC
    AMERICAN JOURNAL OF HEMATOLOGY, 1992, 40 (04) : 259 - 263
  • [27] Effect of interferon-α on CD20 antigen expression of B-cell chronic lymphocytic leukemia
    Sivaraman, S
    Venugopal, P
    Ranganathan, R
    Deshpande, CG
    Huang, X
    Jajeh, A
    Gregory, SA
    O'Brien, T
    Preisler, HD
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 2000, 6 (02) : 81 - 87
  • [28] Loss of CD20 expression following treatment with anti-CD20 monoclonal antibody in chronic lymphocytic leukemia.
    Savage, KJ
    Weng, AP
    Kutok, JL
    Pinkus, G
    Gribben, JG
    BLOOD, 2002, 100 (11) : 364B - 364B
  • [29] THE ROLE OF CD20 AND CD19 WITH THEIR FLOW CYTOMETRIC PARAMETERS IN DIFFERENTIATION BETWEEN CHRONIC LYMPHOCYTIC LEUKAEMIA/SMALL LYMPHOCYTIC LYMPHOMA AND OTHER B-CELL NON HODGKIN'S LYMPHOMA
    Al-Tayeb, Osama
    Osman, Ihsan
    Abdulaziz, Mohamed
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2012, 34 : 43 - 44
  • [30] High CD79b Expression Predicts a Poor Outcome in B-Cell Chronic Lymphocytic Leukemia (B-CLL).
    Del Poeta, Giovanni
    Del Principe, Maria Ilaria
    Zucchetto, Antonella
    Buccisano, Francesco
    Simotti, Cristina
    Maurillo, Luca
    Gianni, Laura
    Bulian, Pietro
    Venditti, Adriano
    Coletta, Angela
    Niscola, Pasquale
    de Fabritiis, Paolo
    Gattei, Valter
    Amadori, Sergio
    BLOOD, 2008, 112 (11) : 386 - 386
12345